- Home
- ACCS vs IINN Comparison
ACCS vs IINN Comparison
Compare ACCS & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACCS | IINN |
|---|---|---|
| Founded | 1988 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Publishing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.0M | 35.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ACCS | IINN |
|---|---|---|
| Price | $7.31 | $0.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $14.00 | $2.00 |
| AVG Volume (30 Days) | 14.5K | ★ 388.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.18 | N/A |
| Revenue Next Year | $7.16 | $9,715.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.75 | $0.40 |
| 52 Week High | $13.35 | $1.65 |
Technical Indicators
Market Signals| Indicator | ACCS | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 42.59 | 33.20 |
| Support Level | $6.75 | $0.55 |
| Resistance Level | $8.77 | $1.12 |
| Average True Range (ATR) | 0.34 | 0.03 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 53.33 | 22.33 |
Price Performance
Historical ComparisonAbout ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.